Literature DB >> 23318367

Preparation and evaluation of raloxifene-loaded solid dispersion nanoparticle by spray-drying technique without an organic solvent.

Tuan Hiep Tran1, Bijay K Poudel, Nirmal Marasini, Sang-Cheol Chi, Han-Gon Choi, Chul Soon Yong, Jong Oh Kim.   

Abstract

The aim of this study was to improve the physicochemical properties and bioavailability of a poorly water-soluble drug, raloxifene by solid dispersion (SD) nanoparticles using the spray-drying technique. These spray-dried SD nanoparticles were prepared with raloxifene (RXF), polyvinylpyrrolidone (PVP) and Tween 20 in water. Reconstitution of optimized RXF-loaded SD nanoparticles in pH 1.2 medium showed a mean particle size of approximately 180 nm. X-ray diffraction and differential scanning calorimetry indicated that RXF existed in an amorphous form within spray-dried nanoparticles. The optimized formulation showed an enhanced dissolution rate of RXF at pH 1.2, 4.0, 6.8 and distilled water as compared to pure RXF powder. The improved dissolution of raloxifene from spray-dried SD nanoparticles appeared to be well correlated with enhanced oral bioavailability of raloxifene in rats. Furthermore, the pharmacokinetic parameters of the spray-dried SD nanoparticles showed increased AUC(0-∞) and C(max) of RXF by approximately 3.3-fold and 2.3-fold, respectively. These results suggest that the preparation of RXF-SD nanoparticles using the spray drying technique without organic solvents might be a promising approach for improving the oral bioavailability of RXF.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23318367     DOI: 10.1016/j.ijpharm.2013.01.013

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  15 in total

1.  Development and Evaluation of Artesunate-Loaded Chitosan-Coated Lipid Nanocapsule as a Potential Drug Delivery System Against Breast Cancer.

Authors:  Tuan Hiep Tran; Tuan Duc Nguyen; Bijay Kumar Poudel; Hanh Thuy Nguyen; Jong Oh Kim; Chul Soon Yong; Chien Ngoc Nguyen
Journal:  AAPS PharmSciTech       Date:  2015-03-19       Impact factor: 3.246

2.  Radio Frequency-Activated Nanoliposomes for Controlled Combination Drug Delivery.

Authors:  Swapnil A Malekar; Ashish L Sarode; Alvin C Bach; Arijit Bose; Geoffrey Bothun; David R Worthen
Journal:  AAPS PharmSciTech       Date:  2015-04-22       Impact factor: 3.246

3.  Production of a new platform based on fumed and mesoporous silica nanoparticles for enhanced solubility and oral bioavailability of raloxifene HCl.

Authors:  Jaleh Varshosaz; Ladan Dayani; Sana Pirmardvand Chegini; Mohsen Minaiyan
Journal:  IET Nanobiotechnol       Date:  2019-06       Impact factor: 1.847

Review 4.  Continuous Manufacturing and Molecular Modeling of Pharmaceutical Amorphous Solid Dispersions.

Authors:  Amritha G Nambiar; Maan Singh; Abhishek R Mali; Dolores R Serrano; Rajnish Kumar; Anne Marie Healy; Ashish Kumar Agrawal; Dinesh Kumar
Journal:  AAPS PharmSciTech       Date:  2022-09-02       Impact factor: 4.026

5.  Novel cationic supersaturable nanomicellar systems of raloxifene hydrochloride with enhanced biopharmaceutical attributes.

Authors:  Atul Jain; Rajpreet Kaur; Sarwar Beg; Varun Kushwah; Sanyog Jain; Bhupinder Singh
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

6.  Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study.

Authors:  Nirmal V Shah; Avinash K Seth; R Balaraman; Chintan J Aundhia; Rajesh A Maheshwari; Ghanshyam R Parmar
Journal:  J Adv Res       Date:  2016-03-05       Impact factor: 10.479

Review 7.  Drug-Rich Phases Induced by Amorphous Solid Dispersion: Arbitrary or Intentional Goal in Oral Drug Delivery?

Authors:  Kaijie Qian; Lorenzo Stella; David S Jones; Gavin P Andrews; Huachuan Du; Yiwei Tian
Journal:  Pharmaceutics       Date:  2021-06-15       Impact factor: 6.321

8.  Preformulation and characterization of raloxifene-loaded lipid nanoparticles for transdermal administration.

Authors:  Guilherme L Alves; Fernanda V Teixeira; Priscila Bianca Rodrigues da Rocha; Anna Paula Krawczyk-Santos; Lígia Marquez Andrade; Marcilio Cunha-Filho; Ricardo N Marreto; Stephânia F Taveira
Journal:  Drug Deliv Transl Res       Date:  2021-03-07       Impact factor: 4.617

9.  Improving dissolution and oral bioavailability of pranlukast hemihydrate by particle surface modification with surfactants and homogenization.

Authors:  Eun-Sol Ha; In-hwan Baek; Jin-Wook Yoo; Yunjin Jung; Min-Soo Kim
Journal:  Drug Des Devel Ther       Date:  2015-06-24       Impact factor: 4.162

10.  Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe.

Authors:  Rehmana Rashid; Dong Wuk Kim; Abid Mehmood Yousaf; Omer Mustapha; Jong Hyuck Park; Chul Soon Yong; Yu-Kyoung Oh; Yu Seok Youn; Jong Oh Kim; Han-Gon Choi
Journal:  Int J Nanomedicine       Date:  2015-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.